Skip to main content

Accessibility Tools

Article

Breaking Barriers in Clinical Trial Accessibility in all US 50 States

Introduction

In clinical trials, medication accessibility can be the difference between meeting critical milestones or facing delays. For sponsors and CROs, the challenges are multifaceted – managing logistics, ensuring compliance, and prioritizing patient-centric care. Myonex understands these challenges – which is why we’re thrilled to announce that SaveWay Compounding Pharmacy, a Myonex company, is fully licensed across all 50 United States, opening new doors for clinical trial dispensing and distribution.
Global Clinical Trial Drug Supply – Research Pharmacy Network

Challenge

Clinical trials often face hurdles in drug distribution, particularly in decentralized and hybrid studies. Licensing restrictions limit patient reach, causing delays and adding layers of complexity to trial logistics. These barriers disrupt timelines and budgets, ultimately delaying life-saving treatments for patients.

 

A Nationwide Network

With our fully-owned compounding pharmacy licensed in all 50 states, sponsors and CROs can now count on seamless medication dispensing and distribution directly to patients’ homes or to clinical sites. These integrated services include:

  • Direct-to-Patient (DtP) shipping for investigational products (IMPs) and commercial medications.
  • Access to sterile and non-sterile compounding, supporting diverse trial needs – such as API powder compounding or injectable sterile compounding.
  • USP 797 compliant sterile operations.
  • National Association Boards of Pharmacy (NABP) inspected and compliant with all required licensures
  • Third-party sterility and potency validation of compounding preparations
  • Expert management of investigational drug compounding, labeling, and cold-chain logistics.

 

Real-World Impact

1. Our expanded licensing enabled faster trial initiation by supplementing high-demand medications for 200 patients. By leveraging our capabilities, the trial met recruitment goals ahead of schedule, utilizing our pharmacy as a unique sourcing pathway and demonstrating how comprehensive pharmacy services can support your trial.

Learn More

2. In a separate study, our advanced pharmacy capabilities enabled the delivery of complex chemotherapy preparations to clinical trial sites without sterile compounding capabilities. By leveraging these capabilities and licensure, we facilitated access to the allogeneic cell therapies without compromising protocol and abilities of clinical sites.

Learn More

3. A sponsor needed to leverage both compounding of active pharmaceutical ingredient (API) and direct to patient (DTP) services for patients in North Carolina, turning to Myonex’s pharmacy to enable expanded access to investigational treatments for patients in North Carolina—an area previously unreachable due to licensing restrictions.

Learn More

Commitment to Excellence

Our nationwide reach means trials can now access previously underserved regions, ensuring equity in research participation and reducing site burdens. Whether supporting compassionate use programs, hybrid studies, or complex investigational therapies, Myonex’s pharmacy services adapt to the unique demands of your study. Our pharmacy is staffed and supported by pharmacists with years of research experience.

Patient-centricity

At Myonex, we understand that the true measure of a successful clinical trial is the positive impact it has on patients. Our pharmacy services through SaveWay are designed to expand access to life-changing treatments, ensuring patients benefit at every step of the journey:

  • Patient Convenience: Myonex empowers patients to participate in clinical trials from the comfort of their own homes or through local care sites, removing traditional barriers and making trials more accessible than ever.
  • Patient Diversity: With a nationwide reach, Myonex connects underserved communities in hard-to-reach locations to groundbreaking clinical trials, fostering inclusivity and advancing equitable healthcare access.
Closeup of pharmacist hand holding bottle while weighing white powder chemical in a laboratory

Conclusion

We are not just expanding licenses – we’re expanding possibilities. By removing logistical barriers, we ensure that clinical trials succeed where they matter most – improving patient outcomes.

Ready to streamline your clinical trial logistics? Contact us today and discover how Myonex’s fully-owned compounding pharmacy can make the difference.